8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 12, 2023 · 2y ago · Accession 0001104659-23-099831
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- 8-K
- Filing date
- Sep 12, 2023
- Report date
- Sep 12, 2023
- Document
- tm2325915d1_8k.htm
- Size
- 7.2 MB